Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 263,139 | 260,927 | 254,455 | 245,428 | 247,006 |
| Cost of Goods | 163,503 | 163,645 | 160,958 | 155,341 | 156,380 |
| Gross Profit | 99,636 | 97,282 | 93,497 | 90,087 | 90,626 |
| Operating Expenses | 18,270 | 18,890 | 18,587 | 15,048 | 18,880 |
| Operating Income | 81,869 | 79,037 | 75,868 | 75,380 | 72,126 |
| Interest Expense | 2,263 | 2,269 | 2,292 | 2,160 | 2,178 |
| Pre-tax Income | 79,606 | 76,768 | 73,576 | 73,220 | 69,948 |
| Income Tax | 19,664 | 20,036 | 18,394 | 18,671 | 16,997 |
| Net Income Continuous | 59,942 | 56,732 | 55,182 | 54,549 | 52,951 |
| Minority Interests | 266 | 216 | 381 | 146 | 35 |
| Net Income | $59,676 | $56,516 | $54,801 | $54,403 | $52,916 |
| EPS Basic Total Ops | 1.30 | 1.22 | 1.19 | 1.15 | 1.11 |
| EPS Basic Continuous Ops | 1.31 | 1.23 | 1.19 | 1.15 | 1.12 |
| EPS Diluted Total Ops | 1.29 | 1.22 | 1.16 | 1.14 | 1.11 |
| EPS Diluted Continuous Ops | 1.30 | 1.22 | 1.17 | 1.15 | 1.11 |
| EBITDA(a) | $87,833 | $85,062 | $81,366 | $81,839 | $77,203 |